74.00
price down icon0.05%   -0.04
after-market アフターアワーズ: 75.00 1.00 +1.35%
loading
前日終値:
$74.04
開ける:
$74
24時間の取引高:
229.80K
Relative Volume:
0.63
時価総額:
$1.70B
収益:
$923.71M
当期純損益:
$84.68M
株価収益率:
18.77
EPS:
3.9419
ネットキャッシュフロー:
$182.81M
1週間 パフォーマンス:
-2.81%
1か月 パフォーマンス:
-2.18%
6か月 パフォーマンス:
-0.09%
1年 パフォーマンス:
-20.75%
1日の値動き範囲:
Value
$73.30
$74.97
1週間の範囲:
Value
$73.30
$79.43
52週間の値動き範囲:
Value
$69.58
$97.00

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name
名前
Ani Pharmaceuticals Inc
Name
セクター
Healthcare (1067)
Name
電話
(609) 759-1810
Name
住所
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, MN
Name
職員
970
Name
Twitter
Name
次回の収益日
2026-11-06
Name
最新のSEC提出書
Name
ANIP's Discussions on Twitter

Compare ANIP vs TAK, TEVA, HLN, ZTS, VTRS

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANIP icon
ANIP
Ani Pharmaceuticals Inc
74.00 1.70B 923.71M 84.68M 182.81M 3.9419
TAK icon
TAK
Takeda Pharmaceutical Co Adr
18.86 59.37B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
39.19 46.91B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
9.26 40.55B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
71.05 29.04B 9.51B 2.64B 2.14B 6.0361
VTRS icon
VTRS
Viatris Inc
17.83 20.01B 14.57B -296.50M 1.64B -0.259

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 開始されました H.C. Wainwright Buy
2025-03-14 開始されました Jefferies Buy
2025-03-12 開始されました JP Morgan Overweight
2024-12-11 開始されました Leerink Partners Outperform
2024-10-11 開始されました Piper Sandler Overweight
2024-03-15 開始されました CapitalOne Overweight
2023-08-22 繰り返されました H.C. Wainwright Buy
2023-03-01 開始されました Guggenheim Buy
2022-09-07 開始されました H.C. Wainwright Buy
2021-11-02 開始されました Truist Buy
2020-05-07 ダウングレード Cantor Fitzgerald Overweight → Neutral
2019-09-12 開始されました Guggenheim Buy
2019-05-10 ダウングレード Raymond James Strong Buy → Outperform
2017-10-16 繰り返されました Canaccord Genuity Buy
2017-07-31 開始されました Canaccord Genuity Buy
2017-02-22 ダウングレード ROTH Capital Buy → Neutral
2016-06-23 開始されました Raymond James Strong Buy
2016-05-24 ダウングレード Standpoint Research Buy → Hold
2015-11-13 開始されました Standpoint Research Buy
2015-09-28 アップグレード ROTH Capital Neutral → Buy
2015-08-05 繰り返されました Oppenheimer Outperform
2015-08-04 繰り返されました ROTH Capital Neutral
2015-07-31 繰り返されました Oppenheimer Outperform
2015-07-15 繰り返されました ROTH Capital Neutral
2015-06-23 繰り返されました Oppenheimer Outperform
2015-05-18 繰り返されました ROTH Capital Neutral
2015-05-06 繰り返されました Oppenheimer Outperform
2015-04-10 ダウングレード ROTH Capital Buy → Neutral
2015-02-26 繰り返されました ROTH Capital Buy
2015-02-18 繰り返されました Oppenheimer Outperform
すべてを表示

Ani Pharmaceuticals Inc (ANIP) 最新ニュース

pulisher
Sep 24, 2026

ANIP5868601 Bond Profile: Coupon and Redemption - TradingView

Sep 24, 2026
pulisher
Sep 24, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, News, Quote & History - ca.finance.yahoo.com

Sep 24, 2026
pulisher
Sep 24, 2026

ANI Pharmaceuticals: Cortrophin’s Q4 Test, With Generics Funding The Build (NASDAQ:ANIP) - Seeking Alpha

Sep 24, 2026
pulisher
Sep 24, 2026

ANI Pharmaceuticals, Inc. (ANIP) Stock forecasts - Yahoo Finance Singapore

Sep 24, 2026
pulisher
Sep 23, 2026

ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - ca.finance.yahoo.com

Sep 23, 2026
pulisher
Sep 23, 2026

Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance

Sep 23, 2026
pulisher
Sep 23, 2026

ANI Pharmaceuticals, Inc. (ANIP) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 23, 2026

ANI Pharmaceuticals gets FDA approval for generic everolimus - Investing.com

Sep 23, 2026
pulisher
Sep 23, 2026

Oppenheimer initiates ANI Pharmaceuticals stock with Perform rating - Investing.com

Sep 23, 2026
pulisher
Sep 23, 2026

ANI Pharmaceuticals gets FDA approval for generic everolimus By Investing.com - Investing.com UK

Sep 23, 2026
pulisher
Sep 23, 2026

ANI Pharmaceuticals Receives FDA Approval for Generic Everolimus Tablets for Oral Suspension - Quiver Quantitative

Sep 23, 2026
pulisher
Sep 23, 2026

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension - GlobeNewswire

Sep 23, 2026
pulisher
Sep 23, 2026

Oppenheimer Initiates ANI Pharmaceuticals at Perform With $85 Price Target - Yahoo Finance

Sep 23, 2026
pulisher
Sep 21, 2026

ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth - Eastern Progress

Sep 21, 2026
pulisher
Sep 16, 2026

ANI Pharmaceuticals (ANIP) President & CEO Nikhil Lalwani Sells 5,400 Shares - GuruFocus

Sep 16, 2026
pulisher
Sep 16, 2026

Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) CEO Sells $383,400.00 in Stock - MarketBeat

Sep 16, 2026
pulisher
Sep 16, 2026

ANI Pharmaceuticals (ANIP) CEO sells 5,400 shares in pre-set trading plan - Stock Titan

Sep 16, 2026
pulisher
Sep 16, 2026

Ani Pharmaceuticals director Thoma sells $71,530 in shares By Investing.com - Investing.com South Africa

Sep 16, 2026
pulisher
Sep 15, 2026

ANI Pharmaceuticals (NASDAQ: ANIP) insider lines up $380,000 stock sale for 2026 - Stock Titan

Sep 15, 2026
pulisher
Sep 15, 2026

ANI Pharmaceuticals Executive Cook Meredith Sells 500 Shares at $70.79 Each (NASDAQ: ANIP) - Kalkine Media

Sep 15, 2026
pulisher
Sep 15, 2026

Squarepoint Ops LLC Sells 37,088 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 15, 2026
pulisher
Sep 15, 2026

Ani Pharmaceuticals’ Meredith Cook sells $35,395 in common stock By Investing.com - Investing.com Canada

Sep 15, 2026
pulisher
Sep 14, 2026

Ani Pharmaceuticals’ Meredith Cook sells $35,395 in common stock - Investing.com

Sep 14, 2026
pulisher
Sep 14, 2026

ANI Pharmaceuticals (ANIP) Insider Sale: SVP, General Counsel & Secretary Meredith Cook Sells 500 Shares - GuruFocus

Sep 14, 2026
pulisher
Sep 14, 2026

Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) VP Sells $35,395.00 in Stock - MarketBeat

Sep 14, 2026
pulisher
Sep 14, 2026

Amundi Boosts Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 14, 2026
pulisher
Sep 14, 2026

Jeanne Thoma Sells 1,000 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat

Sep 14, 2026
pulisher
Sep 13, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 13, 2026
pulisher
Sep 13, 2026

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Sep 13, 2026
pulisher
Sep 11, 2026

ANI Pharmaceuticals (NASDAQ: ANIP) director plans $71K share sale - Stock Titan

Sep 11, 2026
pulisher
Sep 11, 2026

WINTON GROUP Ltd Takes $4.56 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 11, 2026
pulisher
Sep 10, 2026

ANI Pharmaceuticals at Wells Fargo conference: rare disease push gains pace - Investing.com

Sep 10, 2026
pulisher
Sep 10, 2026

ANIP: Record growth in rare disease and generics, with strong financials and strategic expansion - TradingView

Sep 10, 2026
pulisher
Sep 09, 2026

ANI Pharmaceuticals stock hits 52-week low at 70.03 USD By Investing.com - Investing.com Nigeria

Sep 09, 2026
pulisher
Sep 09, 2026

ETFs Investing in ANI Pharmaceuticals, Inc. Stocks - TradingView

Sep 09, 2026
pulisher
Sep 09, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 52-Week LowTime to Sell? - MarketBeat

Sep 09, 2026
pulisher
Sep 09, 2026

ANI Pharmaceuticals stock hits 52-week low at 70.03 USD - investing.com

Sep 09, 2026
pulisher
Sep 09, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners - MarketBeat

Sep 09, 2026
pulisher
Sep 05, 2026

Legal & General Group Plc Buys Shares of 45,075 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 05, 2026
pulisher
Sep 04, 2026

ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board - Yahoo Finance

Sep 04, 2026
pulisher
Sep 03, 2026

ANI Pharmaceuticals to Present at September Investor Conferences - The Manila Times

Sep 03, 2026
pulisher
Sep 03, 2026

Corient Private Wealth LP Invests $2.01 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 03, 2026
pulisher
Sep 02, 2026

Ani Pharmaceuticals SVP & CFO Stephen Carey sells $207,480 in stock - Investing.com Nigeria

Sep 02, 2026
pulisher
Sep 01, 2026

ANI Pharmaceuticals (ANIP) SVP & CFO Stephen Carey Sells 2,850 S - GuruFocus

Sep 01, 2026
pulisher
Sep 01, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) CFO Stephen Carey Sells 2,850 Shares - MarketBeat

Sep 01, 2026
pulisher
Aug 31, 2026

79,683 Shares in ANI Pharmaceuticals, Inc. $ANIP Purchased by Jupiter Topco LLC - MarketBeat

Aug 31, 2026
pulisher
Aug 31, 2026

ANI Pharmaceuticals (ANIP) CFO sells 2,850 shares in preset trading plan - Stock Titan

Aug 31, 2026

Ani Pharmaceuticals Inc (ANIP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$19.77
price down icon 0.18%
RDY RDY
$12.25
price down icon 0.41%
$22.31
price down icon 0.18%
$138.40
price down icon 0.39%
$475.45
price up icon 0.69%
$17.83
price up icon 2.35%
大文字化:     |  ボリューム (24 時間):